Sun, Dec 28, 2014, 9:07 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • weightbayou weightbayou Sep 14, 2013 2:51 PM Flag

    US and Russia sign deal. Watch CLDX hit $26 next week.

    Rockefeller University (Rockefeller) – Celldex has licensed intellectual property from Rockefeller to target the DEC-205 family of mannose receptors in human dendritic cells, leveraging discoveries from the laboratories of the late Nobel Laureate Professor Ralph Steinman and Professor Michel Nussenzweig. Celldex is also collaborating with Rockefeller to develop CDX-2401, a novel vaccine against HIV, the virus known to cause AIDS. This project is supported through a grant from the Bill & Melinda Gates Foundation and utilizes human antibodies to DEC-205 receptors to selectively generate robust immune responses against specifically selected HIV antigens.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
18.24+1.16(+6.79%)Dec 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.